UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): September 05, 2001
CELL GENESYS, INC.
(Exact name of registrant as specified in its charter)
342 Lakeside Drive
Foster City, California 94404
(Address of principal executive offices including zip code)
(650) 425-4400
(Registrant's telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Item 5. Other Events
On September 5, 2001, Cell Genesys, Inc. completed its acquisiton of Calydon, Inc. A copy of the press release of Cell Genesys with respect to completion of the acquisition is included herein as Exhibit 99.1 and is incorporated by reference into this item 5.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c)Exhibits
99.1 Press Release, issued September 5, 2001 announcing the completion of the acqusition of Calydon, Inc.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: September 14, 2001
| CELL GENESYS, INC. |
| By: | /s/ Matt Pfeffer |
| Matthew J. Pfeffer | |
| Vice President and Chief Financial Officer (Principal Accounting Officer) |
EXHIBIT INDEX
Exhibit Number |
Description |
99.1 | Press Release dated September 5, 2001. |
